Clinical Trials
4
Active:1
Completed:2
Trial Phases
2 Phases
Phase 1:2
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (66.7%)Phase 2
1 (33.3%)Exploratory Study on Two Different Doses of VML-0001 on the Effects on Vaginal pH in Healthy Post-Menopausal Women
Completed
- Conditions
- Vaginal Atrophy
- First Posted Date
- 2018-12-10
- Last Posted Date
- 2020-10-06
- Lead Sponsor
- Viramal Limited
- Target Recruit Count
- 14
- Registration Number
- NCT03770065
- Locations
- 🇺🇸
Medical Affiliated Research Center, Inc. (MARC), Huntsville, Alabama, United States
Study to Investigate the Pharmacokinetics & Safety Following One Application of 3 Different Doses 0.5,0.75,& 1.25 gm,a Transdermal Estradiol Cream (VML-0203), in Comparison to a Single Dose of EstroGel 1.25 gm to Healthy Post-menopausal Women.
- First Posted Date
- 2018-06-14
- Last Posted Date
- 2022-04-27
- Lead Sponsor
- Viramal Limited
- Target Recruit Count
- 20
- Registration Number
- NCT03556800
- Locations
- 🇬🇧
Simbec Research Ltd, Merthyr Tydfil, Wales, United Kingdom
Study to Determine Intraperitoneal,Tissue, Serum Concentrations of VML-0501 Following Five Days of Daily Vaginal Single Dose of VML-0501 (100 mg Danazol), in Comparison to Oral Danazol Capsules Daily 600 mg), in Women With Signs and Symptoms of Endometriosis Undergoing Laparoscopy
- First Posted Date
- 2017-11-24
- Last Posted Date
- 2020-06-12
- Lead Sponsor
- Viramal Limited
- Target Recruit Count
- 30
- Registration Number
- NCT03352076
- Locations
- 🇮🇹
Ospedale L. Sacco - Milan-Obgyn Unit, Milan, Italy
News
No news found